Kodiak Sciences is trading down 4.09% in pre-market at $84.04, with its $350 million at-the-market equity offering and universal shelf filing renewing attention on potential shareholder dilution. - Available reports do not explicitly confirm the offering caused this pre-market move. - No new company announcement dated October 26 was identified; its latest listed release was October 7.